Galena Biopharma (NASDAQ: GALE) was recently issued an FDA warning letter with respect to its Abstral (fentanyl) sublingual tablets ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE